Presumptive Testing of Amphetamine-Type Stimulants Via Colour Tests
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Powerpoint Slides
Welcome to the 2021 IDS Forensic Science Education Series • Do today: Attorneys – if you would like CLE credit, report your attendance to me using the link that I email you and I will submit your information to the bar. The State Bar will invoice you for $3.50 per hour of CLE credit at the end of the credit year. 60 min of general CLE credit is anticipated. You may only receive credit for attending the live (not recorded) version of the webinar. • Do later: For participants who complete 10 or more webinars in this year’s series and report their credit to me, you’ll receive acknowledgement that you completed this course of forensic education. For this certificate, watching the recorded version is fine. Please report this attendance to me in Dec. 2021. • I will email you the link to report your attendance to me. • Questions? Email [email protected] Edward G. Brown, Ph.D. NC Indigent Defense Services CLE April 1, 2021 Edward G. Brown, Ph.D. Dr. Brown obtained his Bachelor of Science degree in Chemistry from U.C. Berkeley in 1980 and his Doctoral degree in Organic Chemistry from U.C. Davis in 1988. Two post- doctoral chemistry research fellowships from University of Auckland, New Zealand, and Yale University furthered his academic studies in medicinal chemistry and analytical chemistry techniques through 1990. Dr. Brown’s productivity during his career as a medicinal and organic chemistry researcher in academics and while working at several pharmaceutical companies and other laboratories has led to his co-inventorship on ten US patents and his co- authorship on over thirty research articles and conference presentations. -
Analysis of Drugs Manual September 2019
Drug Enforcement Administration Office of Forensic Sciences Analysis of Drugs Manual September 2019 Date Posted: 10/23/2019 Analysis of Drugs Manual Revision: 4 Issue Date: September 5, 2019 Effective Date: September 9, 2019 Approved By: Nelson A. Santos Table of Contents CHAPTER 1 – QUALITY ASSURANCE ......................................................................... 3 CHAPTER 2 – EVIDENCE ANALYSIS ......................................................................... 93 CHAPTER 3 – FIELD ASSISTANCE .......................................................................... 165 CHAPTER 4 – FINGERPRINT AND SPECIAL PROGRAMS ..................................... 179 Appendix 1A – Definitions ........................................................................................... 202 Appendix 1B – Acronyms and Abbreviations .............................................................. 211 Appendix 1C – Instrument Maintenance Schedule ..................................................... 218 Appendix 1D – Color Test Reagent Preparation and Procedures ............................... 224 Appendix 1E – Crystal and Precipitate Test Reagent Preparation and Procedures .... 241 Appendix 1F – Thin Layer Chromatography................................................................ 250 Appendix 1G – Qualitative Method Modifications ........................................................ 254 Appendix 1H – Analytical Supplies and Services ........................................................ 256 Appendix 2A – Random Sampling Procedures -
Screening/Spot Test of Narcotics
Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. -
Download Full Article As
Article Alkaloids Detection in Commonly Found Medicinal Plants with Marquis Reagent Daniel Alejandro Ocampo-Bustos1 and María Elena Cano-Ruiz1 1 Tecnológico de Monterrey High School, Cuernavaca, Mexico. SUMMARY identity of social groups. Many of the medicinal plants have Alkaloids are a class of nitrogenous organic their healing properties known by empirical use through time, compounds of plant origin that may have important but these medicinal plants may contain active ingredients physiological actions on humans. They include many with tested pharmacological properties. One possibility is that drugs and poisons, but some alkaloids in low doses some of the active ingredients in medicinal plants belong to the have health benefits as well. Traditional medicinal group of alkaloids, which can be determined by a colorimetric plants may contain alkaloids as active ingredients, chemical reaction with the Marquis reagent. The reagent is but this is not well-understood. The Marquis reagent dripped onto the substance being tested, and if an alkaloid exists as a simple qualitative colorimetric method is present, a color change appears (5). The Marquis reagent to determine the presence of alkaloids in medicinal is traditionally composed of a mixture of formaldehyde and plants. The Marquis reagent test was assayed in concentrated sulfuric acid. medicinal plants by first optimizing the formulation Originally, the Marquis reagent was used for testing of the reagent using poppy seeds and lavender as many different alkaloids, and the results from those studies the positive and negative controls. Then using the were the base for developing the color scales that are optimized formulation of Marquis reagent in the extracts of 11 medicinal plants with known claims of used as a reference to determine the specific alkaloid health benefits. -
Endogenous Metabolites: JHU NIMH Center Page 1
S. No. Amino Acids (AA) 24 L-Homocysteic acid 1 Glutaric acid 25 L-Kynurenine 2 Glycine 26 N-Acetyl-Aspartic acid 3 L-arginine 27 N-Acetyl-L-alanine 4 L-Aspartic acid 28 N-Acetyl-L-phenylalanine 5 L-Glutamine 29 N-Acetylneuraminic acid 6 L-Histidine 30 N-Methyl-L-lysine 7 L-Isoleucine 31 N-Methyl-L-proline 8 L-Leucine 32 NN-Dimethyl Arginine 9 L-Lysine 33 Norepinephrine 10 L-Methionine 34 Phenylacetyl-L-glutamine 11 L-Phenylalanine 35 Pyroglutamic acid 12 L-Proline 36 Sarcosine 13 L-Serine 37 Serotonin 14 L-Tryptophan 38 Stachydrine 15 L-Tyrosine 39 Taurine 40 Urea S. No. AA Metabolites and Conjugates 1 1-Methyl-L-histidine S. No. Carnitine conjugates 2 2-Methyl-N-(4-Methylphenyl)alanine 1 Acetyl-L-carnitine 3 3-Methylindole 2 Butyrylcarnitine 4 3-Methyl-L-histidine 3 Decanoyl-L-carnitine 5 4-Aminohippuric acid 4 Isovalerylcarnitine 6 5-Hydroxylysine 5 Lauroyl-L-carnitine 7 5-Hydroxymethyluracil 6 L-Glutarylcarnitine 8 Alpha-Aspartyl-lysine 7 Linoleoylcarnitine 9 Argininosuccinic acid 8 L-Propionylcarnitine 10 Betaine 9 Myristoyl-L-carnitine 11 Betonicine 10 Octanoylcarnitine 12 Carnitine 11 Oleoyl-L-carnitine 13 Creatine 12 Palmitoyl-L-carnitine 14 Creatinine 13 Stearoyl-L-carnitine 15 Dimethylglycine 16 Dopamine S. No. Krebs Cycle 17 Epinephrine 1 Aconitate 18 Hippuric acid 2 Citrate 19 Homo-L-arginine 3 Ketoglutarate 20 Hydroxykynurenine 4 Malate 21 Indolelactic acid 5 Oxalo acetate 22 L-Alloisoleucine 6 Succinate 23 L-Citrulline 24 L-Cysteine-glutathione disulfide Semi-quantitative analysis of endogenous metabolites: JHU NIMH Center Page 1 25 L-Glutathione, reduced Table 1: Semi-quantitative analysis of endogenous molecules and their derivatives by Liquid Chromatography- Mass Spectrometry (LC-TripleTOF “or” LC-QTRAP). -
(19) United States (12) Patent Application Publication (10) Pub
US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist. -
Drug Chemistry Procedure Manual 1
Drug Chemistry Procedure Manual 1 SECTION A: Preliminary Tests Marquis Reagent ..................................................................................................... A - 1 Duquenois-Levine Reagent .................................................................................... A - 2 Cobalt Thiocyanate Reagent .................................................................................. A - 3 Ferric Chloride Reagent ......................................................................................... A - 4 Koppanyi Reagent................................................................................................... A - 5 Potassium Permanganate Reagent ...................................................................... A - 6 p-Dimethylaminobenzaldehyde Reagent (PDMAB) .............................................. A - 7 Froehde’s Reagent.................................................................................................. A - 8 Mecke’s Reagent..................................................................................................... A - 9 Silver Nitrate Reagent............................................................................................. A - 10 Zwikker Reagent...................................................................................................... A - 11 Barium Chloride Reagent ....................................................................................... A - 12 Methanolic Potassium Hydroxide Reagent ......................................................... -
INTERNATIONAL COLLABORATIVE EXERCISES (ICE) Summary Report
INTERNATIONAL QUALITY ASSURANCE PROGRAMME (IQAP) INTERNATIONAL COLLABORATIVE EXERCISES (ICE) Summary Report SEIZED MATERIALS 2015/1 INTERNATIONAL QUALITY ASSURANCE PROGRAMME (IQAP) INTERNATIONAL COLLABORATIVE EXERCISES (ICE) Table of contents Introduction Page 3 Comments from the International Panel of Forensic Experts Page 3 NPS reported by ICE participants Page 4 Codes and Abbreviations Page 7 Sample 1 Analysis Page 8 Identified substances Page 8 Statement of findings Page 12 Identification methods Page 21 Summary Page 26 Z-Scores Page 27 Sample 2 Analysis Page 31 Identified substances Page 31 Statement of findings Page 35 Identification methods Page 44 Summary Page 49 Z-Scores Page 50 Sample 3 Analysis Page 53 Identified substances Page 53 Statement of findings Page 55 Identification methods Page 60 Summary Page 65 Sample 4 Analysis Page 66 Identified substances Page 66 Statement of findings Page 71 Identification methods Page 80 Summary Page 85 Z-Scores Page 86 Full test Samples Information Samples Comments on samples Sample 1 SM-1 was prepared from a seizure containing 5.2 % (w/w) cocaine base. The test sample also contained glucose, caffeine, lidocaine, procaine and trace amounts of creatine and levamisole. Sample 2 SM-2 was prepared from a seizure containing 5.5 % (w/w) amfetamine base. The test sample also contained caffeine and creatine. Sample 3 SM-3 was a blank test sample containing no substances from the ICE menu. Sample 4 SM-4 was prepared from a seizure containing 72.2%(w/w) heroin base. the seizure also contained acetylcodeine, -
Mandelin Reagent Instructions 1
MANDELIN REAGENT INSTRUCTIONS 1. Carefully shake bottle before each use. Open the WIM Scientific Laboratories Mandelin Reagent's factory seal. 2. Using the provided mini tester spoon, place at least .010 to .005 Grams (Tiny amount) of the questionable substance into the empty testing vial. 3. Add one or two drops of the Mandelin Reagent into the testing vial. The mandelin reagent is a strong yellow color.* 4. Watch carefully during the reaction time for color changes, any fizzing or smoking. 5. Refer to the color chart (on back) to determine what is present in the sample. 6. Rinse testing vial and the mini tester spoon thoroughly with soap and water after testing. 7. After successfully testing your substance, mini testing spoon and testing vial will need to be completely cleaned and dried before your next use. 8. After testing, the Mandelin Reagent bottle cap should be closed tightly and placed back into the bag to ensure no leakage or unwanted exposure occurs. 9. Also included are glow sticks and wristbands...because we love you. They may come in handy! Mandelin Reagent Kits are made to order with manufacture dates stamped on the bag and will be useful for at least 3-6 months depending on proper storage. Keep out of direct sunlight and hot temperatures (Above 120 degrees) for best results and lasting usage. Please note that a positive or negative reaction for any substance tested does not mean that a substance is safe. No chemical use is 100% safe. This will simply test for the presence of certain substances. -
Presented to the Graduate Council of the University of North Texas in Partial Fulfillment of the Requirements for the Degree Of
3-7? CHEMICAL IONIZATION (CI) GC/MS ANALYSIS OF UNDERIVATIZED AMPHETAMINES FOLLOWED BY CHIRAL DERIVATIZATION TO IDENTIFY d AND 1-ISOMERS WITH ION TRAP MASS SPECTROMETRY THESIS Presented to the Graduate Council of the University of North Texas in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE (Pharmacology) By John A. Tarver B.S.,B.A. May, 1991 Tarver, John A. Chemical Ionization (CI) GC/MS Analysis of Underivatized Amphetamines Followed by Chiral Derivatiza- tion to Identify d and 1-Isomers with Ion Trap Mass Spectro- metry. Master of Science (Biomedical Sciences), May, 1991, 26 pp., 9 figures, bibliography, 20 titles. An efficient two step procedure has been developed using CI GC/MS for analyzing amphetamines and related compounds. The first step allows the analysis of underiv- atized amphetamines with the necessary sensitivity and specificity to give spectral identification, including differentiation between methamphetamine and phentermine. The second step involves preparing a chiral derivative of the extract to identify d and 1-isomeric composition. TABLE OF CONTENTS Page LIST OF ILLUSTRATIONS.......... ... .. .. .......... iv INTRODUCTION .1........................... EXPERIMENTAL MATERIALS ...--- - - - - ----... -....-..... 15 METHODS --------------------.---...... 15 RESULTS AND DISCUSSION ...-..-..................... 17 CONCLUSION - - - - - -- - - - - --- - --- . - . 23 APPENDIX......... ---. -----....-.-. ----.. -........ 24 REFERENCES ----------------------------.. --. ...---.. 28 iii LIST OF ILLUSTRATIONS -
Gc/Ms Assays for Abused Drugs in Body Fluids
GC/MS ASSAYS FOR ABUSED DRUGS IN BODY FLUIDS U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alchol, Drug Abuse, and Mental Health Administration GC/MS Assays for Abused Drugs in Body Fluids Rodger L. Foltz, Ph.D. Center for Human Toxicology University of Utah Salt Lake City, Utah 64112 Allison F. Fentiman, Jr., Ph.D. Ruth B. Foltz Battelle Columbus Laboratories Columbus, Ohio 43201 NIDA Research Monograph 32 August 1980 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Division of Research 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 The NIDA Research Monograph series is prepared by the Division of Research of the National Institute on Drug Abuse. Its primary objective is to provide critical reviews of research problem areas and techniques, the content of state-of-the- art conferences, integrative research reviews and significant original research. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisory Board Avram Goldstein, M.D. Addiction Research Foundation Palo Alto, California Jerome Jaffe, M.D. College of Physicians and Surgeons Columbia University, New York Reese T. Jones, M.D. Langley Porter Neuropsychiatric Institute University of California San Francisco, California William McGlothlin, Ph.D. Department of Psychology, UCLA Los Angeles, California Jack Mendelson, M.D. Alchol and Drug Abuse Research Center Harvard Medical School Mclean Hospital Belmont, Massachusetts Helen Nowlis, Ph.D. Office of Drug Education, DHHS Washington, D.C. -
For Peer Review 19 Studies
Drug Testing and Analysis A review of chemical ‘spot’ tests: a presumptive illicit drug identification technique Journal:For Drug Peer Testing and Analysis Review Manuscript ID DTA-17-0289.R1 Wiley - Manuscript type: Review Date Submitted by the Author: n/a Complete List of Authors: Philp, Morgan; University of Technology Sydney, Centre for Forensic Science Fu, Shanlin; University of Technology Sydney, Centre for Forensic Science presumptive identification, color test, new psychoactive substances, Keywords: chemistry Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used by law enforcement, border security personnel, and forensic laboratories. The simplicity, low cost and rapid results afforded by these tests make them particularly attractive for presumptive identification globally. In this paper, we review the development of these long- established methods and discuss color test recommendations and guidelines. A search of the scientific literature revealed the chemical Abstract: reactions occurring in many color tests are either not actively investigated or reported as unknown. Today, color tests face many challenges, from the appearance of new psychoactive substances to concerns regarding selectivity, sensitivity, and safety. Advances in technology have seen color test reagents used in digital image color analysis, solid sensors and microfluidic devices for illicit drug detection. This review aims to summarize current research and suggest the future of presumptive color testing. http://mc.manuscriptcentral.com/dta Page 1 of 34 Drug Testing and Analysis 1 2 3 A review of chemical ‘spot’ tests: a presumptive illicit drug identification 4 5 technique 6 7 Morgan Philp and Shanlin Fu 8 9 10 11 Short title: Review of chemical spot tests for illicit drug detection 12 13 Chemical ‘spot’ tests are a presumptive illicit drug identification technique commonly used 14 by law enforcement, border security personnel, and forensic laboratories.